We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOPE icon
2276
Grand Canyon Education
LOPE
$4.22B
$602K ﹤0.01%
5,700
-18,218
-76% -$1.82M
EVBG
2277
DELISTED
Everbridge, Inc. Common Stock
EVBG
$601K ﹤0.01%
20,301
+1,968
+11% +$60.3K
SFL icon
2278
SFL Corp
SFL
$1.61B
$600K ﹤0.01%
65,101
-275,952
-81% -$2.68M
VNO icon
2279
Vornado Realty Trust
VNO
$7.65B
$597K ﹤0.01%
+28,684
New +$657K
PED icon
2280
PEDEVCO
PED
$144M
$596K ﹤0.01%
27,070
-5,099
-16% -$119K
BIZD icon
2281
VanEck BDC Income ETF
BIZD
$1.6B
$595K ﹤0.01%
+42,065
New +$614K
UCL
2282
uCloudlink Group
UCL
$33.5M
$594K ﹤0.01%
+177,709
New +$387K
SPOK icon
2283
Spok Holdings
SPOK
$229M
$592K ﹤0.01%
+72,253
New +$587K
HVT icon
2284
Haverty Furniture Companies
HVT
$418M
$589K ﹤0.01%
+19,689
New +$576K
HWC icon
2285
Hancock Whitney
HWC
$6.19B
$588K ﹤0.01%
12,150
-22,053
-64% -$1.14M
RPTX
2286
DELISTED
Repare Therapeutics
RPTX
$581K ﹤0.01%
+39,489
New +$591K
POWW icon
2287
Outdoor Holding Co
POWW
$249M
$581K ﹤0.01%
335,570
+211,995
+172% +$535K
PMVP icon
2288
PMV Pharmaceuticals
PMVP
$57.1M
$576K ﹤0.01%
66,207
+21,000
+46% +$224K
REVEW
2289
CALL
DELISTED
Alpine Acquisition Corp Warrant
REVEW
$575K ﹤0.01%
55,079
DRD
2290
DRDGold
DRD
$1.75B
$573K ﹤0.01%
77,482
-11,518
-13% -$70.9K
WSO icon
2291
Watsco Inc
WSO
$13.2B
$573K ﹤0.01%
+2,297
New +$604K
WE.WS
2292
CALL
DELISTED
WeWork Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
WE.WS
$572K ﹤0.01%
400,000
-150,000
-27% -$40K
LKFN icon
2293
Lakeland Financial Corp
LKFN
$1.57B
$567K ﹤0.01%
+7,765
New +$595K
CQQQ icon
2294
Invesco China Technology ETF
CQQQ
$3.01B
$566K ﹤0.01%
+13,030
New +$500K
WYNN icon
2295
Wynn Resorts
WYNN
$10.3B
$565K ﹤0.01%
6,855
TRCA.WS
2296
CALL
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
$565K ﹤0.01%
56,026
-112,699
-67% -$4.38K
TE
2297
T1 Energy
TE
$1.04B
$565K ﹤0.01%
65,092
+47,991
+281% +$601K
NRDY.WS
2298
CALL
DELISTED
Nerdy Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
NRDY.WS
$563K ﹤0.01%
250,000
-165,990
-40% -$44.3K
ZIMV
2299
DELISTED
ZimVie
ZIMV
$562K ﹤0.01%
+60,218
New +$526K
PID icon
2300
Invesco International Dividend Achievers ETF
PID
$936M
$562K ﹤0.01%
+33,635
New +$553K

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.